cell

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

April 27, 2026 17:00 ET  | Source: ElevateBio – Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s…

1 week ago

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

April 27, 2026 17:00 ET  | Source: Arbor Biotechnologies Inc - Oral presentation highlights novel compact RT editor demonstrating first…

1 week ago

Herbalife India and IIT Madras Sign a Landmark Agreement to Establish India’s First Centre of Excellence on Plant Cell Fermentation

BANGALORE, India, April 16, 2026 /PRNewswire/ -- Herbalife International India Private Limited and the Indian Institute of Technology Madras have…

3 weeks ago

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

April 13, 2026 09:00 ET  | Source: Senti Biosciences, Inc. SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) --…

3 weeks ago

ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems

Offering a new, validated CCS design pathway, reducing uncertainty for cautious battery engineersNECKARSULM, Germany, March 25, 2026 /PRNewswire/ -- ENNOVI,…

1 month ago

NYUCT Design Labs launches Edible Ventures, a first-of-its-kind, full stack design and development cell for food & restaurant brands

MUMBAI, India, March 19, 2026 /PRNewswire/ -- NYUCT Design Labs, India's first Venture Design and Experience Innovation Collective, announced the…

2 months ago

REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs

Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing ServicesBELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today…

2 months ago

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…

3 months ago

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET  | Source:…

3 months ago

MEDEZE Receives Frost & Sullivan’s 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine

The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast AsiaSAN ANTONIO, Dec. 15, 2025 /PRNewswire/…

5 months ago